000 01687 a2200517 4500
005 20250515165244.0
264 0 _c20090612
008 200906s 0 0 eng d
022 _a0264-410X
024 7 _a10.1016/j.vaccine.2009.02.064
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMinor, Philip D
245 0 0 _aCurrent challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK.
_h[electronic resource]
260 _bVaccine
_cMay 2009
300 _a2907-13 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aDrug Approval
650 0 4 _aHumans
650 0 4 _aInfluenza Vaccines
_xadverse effects
650 0 4 _aOrthomyxoviridae
_xgenetics
650 0 4 _aReassortant Viruses
_xgenetics
650 0 4 _aUnited Kingdom
650 0 4 _aVirus Cultivation
_xmethods
700 1 _aEngelhardt, Othmar G
700 1 _aWood, John M
700 1 _aRobertson, James S
700 1 _aBlayer, Simone
700 1 _aColegate, Tony
700 1 _aFabry, Luc
700 1 _aHeldens, Jacco G M
700 1 _aKino, Yoichiro
700 1 _aKistner, Otfried
700 1 _aKompier, Ronald
700 1 _aMakizumi, Keiichi
700 1 _aMedema, Jeroen
700 1 _aMimori, Shigetaka
700 1 _aRyan, David
700 1 _aSchwartz, Richard
700 1 _aSmith, Jonathan S B
700 1 _aSugawara, Keishin
700 1 _aTrusheim, Heidi
700 1 _aTsai, Theodore F
700 1 _aKrause, Ryoko
773 0 _tVaccine
_gvol. 27
_gno. 22
_gp. 2907-13
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2009.02.064
_zAvailable from publisher's website
999 _c18798739
_d18798739